HDAC1 and non-small cell lung carcinoma: Here, we disclosed that paclitaxel-resistant NSCLC cells displayed the enhanced HDAC activity, increased HDAC1 expression, and raised cell proliferation ability in vitro and in vivo, and HDAC1 knockdown could sensitize resistant cells to paclitaxel in vitro.